C, L., MN, G., SE, T., AE, S., E, P., AM, R., . . . LB, W. (2026). Inhibition of p38 MAPK after repetitive mTBI ameliorates immune signaling and functional deficits. Acta neuropathologica communications, 14(1), . https://doi.org/10.1186/s40478-026-02226-w
Chicago Style (17th ed.) CitationC, Li, et al. "Inhibition of P38 MAPK After Repetitive MTBI Ameliorates Immune Signaling and Functional Deficits." Acta Neuropathologica Communications 14, no. 1 (2026). https://doi.org/10.1186/s40478-026-02226-w.
MLA (9th ed.) CitationC, Li, et al. "Inhibition of P38 MAPK After Repetitive MTBI Ameliorates Immune Signaling and Functional Deficits." Acta Neuropathologica Communications, vol. 14, no. 1, 2026, https://doi.org/10.1186/s40478-026-02226-w.
Warning: These citations may not always be 100% accurate.